SEATTLE, Sept. 11, 2012 - For patients too sick to undergo open-heart surgery, a new, FDA-approved, minimally invasive aortic valve replacement procedure - now being performed by Swedish Heart & Vascular Institute (SHVI) providers - is offering new hope to patients whose life-threatening heart condition was previously inoperable.
EverydayHealth.com posted a story about this new procedure - called Transcatheter Aortic Valve Replacement - on their web site. The piece includes a two-minute-long video and transcript featuring interviews with SHVI physicians involved with these cases as well as personal perspectives from an 88-year-old woman from Olympia, Wash. who recently underwent the procedure at Swedish/Cherry Hill and is glad it was an available option.
To view the story on EverydayHealth.com and/or read the transcript, click here.
For more information about SHVI's TAVR program, e-mail firstname.lastname@example.org.